Anzalone Christopher Richard Insider Trading Activity
Anzalone Christopher Richard has been net-selling over the last 12 months with 0 purchases and 25 sales across 1 company.
ARWR is the most-traded position with 25 trades. The largest single transaction was a sale of ARWR for $6.9M on Dec 15, 2025.
Performance Scorecard
Forward stock performance after each transaction by Anzalone Christopher Richard. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -0.3% | 60% | 25 |
| 90 days | — | +12.8% | 100% | 25 |
| 120 days | — | -6.2% | 12% | 25 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersARWR · ARROWHEAD PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Anzalone Christopher Richard bought and sold ARWR.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | ARWR | Sell | 5,771 | $66.39 | $383K | CEO |
| Jan 2, 2026 | ARWR | Sell | 7,416 | $65.88 | $489K | CEO |
| Dec 29, 2025 | ARWR | Sell | 35,181 | $69.33 | $2.4M | CEO |
| Dec 29, 2025 | ARWR | Sell | 16,545 | $68.69 | $1.1M | CEO |
| Dec 22, 2025 | ARWR | Sell | 2,574 | $68.85 | $177K | CEO |
| Dec 22, 2025 | ARWR | Sell | 10,012 | $68.33 | $684K | CEO |
| Dec 19, 2025 | ARWR | Sell | 1,319 | $68.48 | $90K | CEO |
| Dec 19, 2025 | ARWR | Sell | 3,979 | $66.67 | $265K | CEO |
| Dec 19, 2025 | ARWR | Sell | 8,147 | $68.01 | $554K | CEO |
| Dec 17, 2025 | ARWR | Sell | 1,981 | $66.30 | $131K | CEO |
| Dec 17, 2025 | ARWR | Sell | 46,287 | $63.55 | $2.9M | CEO |
| Dec 17, 2025 | ARWR | Sell | 35,750 | $64.51 | $2.3M | CEO |
| Dec 17, 2025 | ARWR | Sell | 982 | $65.53 | $64K | CEO |
| Dec 16, 2025 | ARWR | Sell | 3,221 | $67.87 | $219K | CEO |
| Dec 16, 2025 | ARWR | Sell | 1,000 | $64.96 | $65K | CEO |
| Dec 16, 2025 | ARWR | Sell | 1,300 | $65.77 | $86K | CEO |
| Dec 16, 2025 | ARWR | Sell | 166 | $66.77 | $11K | CEO |
| Dec 16, 2025 | ARWR | Sell | 8,416 | $60.51 | $509K | CEO |
| Dec 16, 2025 | ARWR | Sell | 10,963 | $61.25 | $671K | CEO |
| Dec 16, 2025 | ARWR | Sell | 14,095 | $62.12 | $876K | CEO |
| Dec 16, 2025 | ARWR | Sell | 8,476 | $62.94 | $533K | CEO |
| Dec 16, 2025 | ARWR | Sell | 6,661 | $64.29 | $428K | CEO |
| Dec 15, 2025 | ARWR | Sell | 21,321 | $69.28 | $1.5M | CEO |
| Dec 15, 2025 | ARWR | Sell | 8,147 | $69.96 | $570K | CEO |
| Dec 15, 2025 | ARWR | Sell | 100,532 | $68.67 | $6.9M | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 25 | $24.0M |
Other insiders at ARROWHEAD PHARMACEUTICALS, INC.
6 other tracked filers at ARWR.